share_log

司太立(603520.SH)发布前三季度业绩,净利润898万元,同比下降77.17%

Zhejiang Starry Pharmaceutical (603520.SH) released its performance for the first three quarters, with a net income of 8.98 million yuan, a year-on-year decrease of 77.17%.

Zhitong Finance ·  Oct 30 06:55

Zhejiang Starry Pharmaceutical (603520.SH) disclosed the third quarter report for 2024, achieving revenue of 18....

Zhongtong Finance APP news, Zhejiang Starry Pharmaceutical (603520.SH) disclosed the third quarter report for 2024, achieving revenue of 1.805 billion yuan, a year-on-year growth of 10.65%; net income attributable to the mother 8.98 million yuan, a year-on-year decrease of 77.17%; non-net profit 4.34 million yuan, a year-on-year decrease of 84.06%; basic earnings per share 0.02 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment